IvoryPixivorypix.hashnode.dev·Dec 5, 2024Dog Bathtub Svg Bundle🔍 Check out Dog Bathtub Svg Bundle now! Explore this 📁 printable illustrations and claim your 🆓 free download here. Let's start crafting together! 🚀 Welcome to my store! You will get SVG and PNG files. Best quality! SVG and PNG are universal file...Discussarea
PawHavenpawhaven.hashnode.dev·Nov 25, 2024Mental Self Care WorkbookIntroduction to Your Mental Self Care Workbook Welcome to your journey of introspection and growth with the Mental Self Care Workbook! In an age where mental wellness is gaining the attention it deserves, creating a sustainable self-care routine has ...Discussboosters
LushKitslushkits.hashnode.dev·Nov 9, 2024Alopecia Awareness: Vector Illustrations in Healthcare CommunicationUnderstanding Alopecia: Use of Vector Illustrations in Healthcare Communication Alopecia, a condition characterized by hair loss, affects millions of people worldwide. It can arise from various causes, including autoimmune diseases, genetics, and str...Discussbaldspot
Larvol Cliniclarvol.hashnode.dev·Sep 27, 2024Gilteritinib Plus Azacitidine for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia: Phase 3 Study Design and Preliminary ResultsBackground: Gilteritinib is an oral FMS-like tyrosine kinase 3 (FLT3) inhibitor that has demonstrated efficacy with favorable tolerability in patients with FLT3-mutated (FLT3mut+) relapsed/refractory acute myeloid leukemia (AML), including internal t...DiscussCancer
Larvol Cliniclarvol.hashnode.dev·Sep 27, 2024Understanding Distress in Advanced Cancer Patients: A Qualitative Analysis of the P-COCC ValuesBackground: Person-Centered Oncologic Care and Choices (P-COCC) is a validated ACP paradigm of a values-focused patient (pt) interview augmented by an informational care goals video. In a randomized trial (Epstein et al ASCO 2017), P-COCC was accepta...DiscussCancer
Larvol Cliniclarvol.hashnode.dev·Sep 27, 2024Outcomes of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma and Deteriorating Liver FunctionBackground The treatment landscape for patients with unresectable hepatocellular carcinoma (uHCC) has recently expanded. However, there is an unmet need for effective treatment options in patients with Child-Pugh (CP) B liver function. Lenvatinib is ...DiscussCancer
Larvol Cliniclarvol.hashnode.dev·Sep 20, 2024Single-Cell DNA Sequencing Reveals Clonal Dynamics in FLT3-Mutated Acute Myeloid Leukemia during Crenolanib Combination TherapyBackgroundSingle cell RNA (scRNA) sequencing analysis suggests that the presence of FLT3-ITD mutation is associated with a progenitor-like phenotype (1van Galen, et al. Cell, 2019: 176, 1265) while activating mutations in the FLT3 kinase domain are a...DiscussTumor
Larvol Cliniclarvol.hashnode.dev·Sep 20, 2024Phase 3 Trial of Gilteritinib Plus Azacitidine vs. Azacitidine Alone in Newly Diagnosed FLT3-Mutated Acute Myeloid LeukemiaBackground: Gilteritinib is an oral FMS-like tyrosine kinase 3 (FLT3) inhibitor that has demonstrated efficacy with favorable tolerability in patients with FLT3-mutated (FLT3mut+) relapsed/refractory acute myeloid leukemia (AML), including internal t...DiscussTumor
Larvol Cliniclarvol.hashnode.dev·Sep 20, 2024A Phase I Study of a Novel Anti-PD-1 Monoclonal AntibodyPF-06801591 is a humanized IgG4 monoclonal antibody that binds to programmed cell death (PD-1) receptor, blocking its interaction with PD-1 ligands. In a phase I study (NCT02573259; dose-escalation) of 40 patients (pts) with multiple solid tumor type...DiscussTumor
Larvol Cliniclarvol.hashnode.dev·Sep 20, 2024Erlotinib and Proton Therapy for Locally Advanced Pancreatic Cancer: A Phase II TrialPurpose/Objective(s): Epidermal growth factor receptor (EGFR) is overexpressed in pancreatic cancer. EGFR expression plays a potentially important role in modulation of tumor sensitivity to either chemotherapy or radiotherapy. Erlotinib is a receptor...DiscussTumor
